{"schema_version":"secwatch.filing_event.v1","accession":"0000075252-23-000042","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2023-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.601644+00:00","generated_at":"2026-06-12T06:40:31.076098+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Owens & Minor Q2 net loss $0.37/share; revenue up 2.5% to $2.56B; adjusted EPS $0.18","bullets":["GAAP net loss per share $(0.37) vs prior year $0.37; adjusted EPS $0.18 vs $0.76.","Revenue $2.56B, up 2.5% YoY; Patient Direct segment double-digit growth drove top line.","Operating cash flow $313M including $115M receivables sales; net debt reduced $269M.","Products & Healthcare Services segment saw Global Products headwinds; management cautious on H2 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000075252-23-000042","json":"https://secwatch.observer/filing/0000075252-23-000042.json","markdown":"https://secwatch.observer/filing/0000075252-23-000042.md","text":"https://secwatch.observer/filing/0000075252-23-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/0000075252-23-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/omi-20230804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T06:40:31.076098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0257a02b25e788cc9312ba91a7d40d3aab3fc32f","claim":"ACCENDRA HEALTH INC/VA/ reported six months ended June 30, 2023 results: revenue $5,086, net income $(52.7), EPS $(0.70).","evidence_excerpt":"Financial Summary (1) YTD YTD ($ in millions, except per share data) 2Q23 2Q22 2023 2022 Revenue $2,563 $2,500 $5,086 $4,907 Operating income, GAAP $10.8 $75.1 $20.6 $136.1 Adj. Operating Income, Non-GAAP $62.0 $113.6 $109.7 $218.5 Net (loss) income, GAAP $(28.2) $28.6 $(52.7) $67.9 Adj. Net Income, Non-GAAP $14.2 $58.3 $17.8 $131.0 Adj. EBITDA, Non-GAAP $112.8 $163.4 $221.5 $285.9 Net (loss) income per common share, GAAP $(0.37) $0.37 $(0.70) $0.89 Adj. Net Income per share, Non-GAAP $0.18 $0.76 $0.23 $1.72","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/0000075252-23-000042-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"six months ended June 30, 2023"},{"label":"Revenue","value":"$5,086"},{"label":"Net income","value":"$(52.7)"},{"label":"EPS","value":"$(0.70)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c766656a9733670b80104574293a9a816f496fae","claim":"ACCENDRA HEALTH INC/VA/ reported second quarter ended June 30, 2023 results: revenue $2.56 billion, net income $(0.37) per common share, EPS $(0.37) per common share.","evidence_excerpt":"Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: • Consolidated revenue of $2.56 billion • Net loss per common share of $(0.37) and adjusted net income per common share of $0.18","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000007525223000042/0000075252-23-000042-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$2.56 billion"},{"label":"Net income","value":"$(0.37) per common share"},{"label":"EPS","value":"$(0.37) per common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}